Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 17:9:1150-1171.
doi: 10.1016/j.toxrep.2022.05.009. eCollection 2022.

Smoking and apolipoprotein levels: A meta-analysis of published data

Alba Romero Kauss  1 , Meagan Antunes  1 , Guillaume de La Bourdonnaye  1 , Sandrine Pouly  1 , Matthew Hankins  1 , Annie Heremans  1 , Angela van der Plas  1
Affiliations

Smoking and apolipoprotein levels: A meta-analysis of published data

Alba Romero Kauss et al. Toxicol Rep. .

Abstract

Background: Apolipoproteins are major components of lipoproteins such as high-density lipoprotein (HDL) and very-low-density lipoprotein and are considered nontraditional markers in the risk assessment for cardiovascular disease. The goal of this review was to quantify the effects of smoking and smoking cessation on serum levels of apolipoproteins AI, AII, and B and the ratio of apolipoproteins B and AI.

Methods: PubMed and Scopus were searched up to June 2021 to identify publications that reported the levels of apolipoproteins AI, AII, and B and the apolipoprotein B/AI ratio in smokers and nonsmokers as well as articles reporting the effect of smoking cessation on the same endpoints. Meta-analyses were performed when a sufficient number (n ≥ 3) of articles evaluating the same outcome were available.

Results: Forty-nine studies had assessed apolipoprotein levels in smokers and nonsmokers. The meta-analyses comparing the levels of apolipoproteins AI and AII showed decreased levels in smokers relative to nonsmokers. On the other hand, the apolipoprotein B levels and apolipoprotein B/AI ratio were increased in smokers relative to nonsmokers. Insufficient publications were available on which to perform meta-analyses on the effects of smoking cessation on apolipoprotein levels.

Conclusions: Smoking is associated with reduced levels of apolipoproteins AI and AII (in line with reduced levels of HLD-cholesterol) and increased apolipoprotein B levels and apolipoprotein B/AI ratio, thereby confirming the negative impact of smoking on lipid metabolism, which contributes to increased cardiovascular risk. More data are needed to elucidate the effects of smoking cessation on these cardiovascular risk endpoints.

Keywords: Apolipoprotein; Cardiovascular disease; Smoking; Tobacco.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: All authors are employed by Philip Morris International.

Figures

Fig. 1
Fig. 1
Prisma flow diagram – article retrieval process.
Fig. 2
Fig. 2
Funnel plot of studies reporting apolipoprotein AI levels (g/L).
Fig. 3
Fig. 3
Funnel plot of studies reporting apolipoprotein AII levels (g/L).
Fig. 4
Fig. 4
Funnel plot of studies reporting apolipoprotein B levels (g/L).
Fig. 5
Fig. 5
Funnel plot of studies reporting apolipoprotein B:AI ratio.
See this image and copyright information in PMC

References

    1. Haapanen A., et al. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation. 1989;80(1):10–16. - PubMed
    1. Kostis J.B., Turkevich D., Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am. J. Cardiol. 1984;53(8):997–999. - PubMed
    1. Alberg A.J., Shopland D.R., Cummings K.M. The 2014 Surgeon General’s report: commemorating the 50th Anniversary of the 1964 report of the advisory committee to the US surgeon general and updating the evidence on the health consequences of cigarette smoking. Am. J. Epidemiol. 2014;179(4):403–412. - PMC - PubMed
    1. Rempher K.J. Cardiovascular sequelae of tobacco smoking. Crit. Care Nurs. Clin. North Am. 2006;18(1):13–20. - PubMed
    1. Frei B., et al. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protect. Effect. Ascorb. Acid. Biochem. J. 1991;277(Pt 1):133–138. - PMC - PubMed

LinkOut - more resources